Skip to main content
Clinical Trials/ISRCTN53323164
ISRCTN53323164
Active, not recruiting
未知

Integrating specialist palliative care to improve care and reduce suffering: cystic fibrosis

Emory University0 sites264 target enrollmentOctober 9, 2020

Overview

Phase
未知
Intervention
Not specified
Conditions
Cystic fibrosis in adults
Sponsor
Emory University
Enrollment
264
Status
Active, not recruiting
Last Updated
3 years ago

Overview

Brief Summary

2022 Protocol article in https://pubmed.ncbi.nlm.nih.gov/36126995/ (added 27/09/2022)

Registry
who.int
Start Date
October 9, 2020
End Date
March 31, 2024
Last Updated
3 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. English\-speaking
  • 2\. Age \=18 years
  • 3\. Palliative needs, as indicated by the following criteria:
  • 3\.1\. \=1 moderate or severe symptom (captured by the Integrated Palliative Outcomes Scale \[IPOS]); OR
  • 3\.2\. Reduced QoL (as captured by the IPOS); OR
  • 3\.3\. \=2 hospitalizations in the preceding year

Exclusion Criteria

  • 1\. Post lung transplant
  • 2\. Patient does not receive primary CF care from the study site or intends to transfer primary CF care elsewhere over the next year
  • 3\. Received outpatient specialty palliative care within the past 12 months
  • 4\. Lack of reliable telephone or internet access
  • 5\. Active suicidal ideation

Outcomes

Primary Outcomes

Not specified

Similar Trials